These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Zarate CA; Singh J; Manji HK Biol Psychiatry; 2006 Jun; 59(11):1006-20. PubMed ID: 16487491 [TBL] [Abstract][Full Text] [Related]
23. Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms. de Queiroz AIG; Chaves Filho AJM; Araújo TDS; Lima CNC; Machado MJS; Carvalho AF; Vasconcelos SMM; de Lucena DF; Quevedo J; Macedo D J Affect Disord; 2018 Jan; 225():40-51. PubMed ID: 28783519 [TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge. Ikonomov OC; Manji HK Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159 [TBL] [Abstract][Full Text] [Related]
26. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158 [TBL] [Abstract][Full Text] [Related]
27. Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression. Du J; Gray NA; Falke C; Yuan P; Szabo S; Manji HK Ann N Y Acad Sci; 2003 Nov; 1003():378-80. PubMed ID: 14684466 [TBL] [Abstract][Full Text] [Related]
28. Neuronal plasticity: a link between stress and mood disorders. Calabrese F; Molteni R; Racagni G; Riva MA Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S208-16. PubMed ID: 19541429 [TBL] [Abstract][Full Text] [Related]
29. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. Wada A J Pharmacol Sci; 2009 May; 110(1):14-28. PubMed ID: 19423950 [TBL] [Abstract][Full Text] [Related]
30. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Chen G; Manji HK Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219 [TBL] [Abstract][Full Text] [Related]
31. Signal transduction pathways. Molecular targets for lithium's actions. Manji HK; Potter WZ; Lenox RH Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629 [TBL] [Abstract][Full Text] [Related]
32. Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice. Böer U; Cierny I; Krause D; Heinrich A; Lin H; Mayr G; Hiemke C; Knepel W Neuropsychopharmacology; 2008 Sep; 33(10):2407-15. PubMed ID: 18046304 [TBL] [Abstract][Full Text] [Related]
33. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge. Rybakowski JK CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337 [TBL] [Abstract][Full Text] [Related]
34. Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons. Park SW; Lee JG; Seo MK; Cho HY; Lee CH; Lee JH; Lee BJ; Baek JH; Seol W; Kim YH Bipolar Disord; 2015 May; 17(3):278-90. PubMed ID: 25307211 [TBL] [Abstract][Full Text] [Related]
35. Molecular Signatures of Lithium Treatment: Current Knowledge. Bellivier F; Marie-Claire C Pharmacopsychiatry; 2018 Sep; 51(5):212-219. PubMed ID: 30060262 [TBL] [Abstract][Full Text] [Related]
36. A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors. Du J; Wei Y; Liu L; Wang Y; Khairova R; Blumenthal R; Tragon T; Hunsberger JG; Machado-Vieira R; Drevets W; Wang YT; Manji HK Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11573-8. PubMed ID: 20534517 [TBL] [Abstract][Full Text] [Related]
37. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Bachmann RF; Schloesser RJ; Gould TD; Manji HK Mol Neurobiol; 2005 Oct; 32(2):173-202. PubMed ID: 16215281 [TBL] [Abstract][Full Text] [Related]
38. Mood disorders: treatment-induced changes in brain neurochemistry and structure. Glitz DA; Manji HK; Moore GJ Semin Clin Neuropsychiatry; 2002 Oct; 7(4):269-80. PubMed ID: 12382209 [TBL] [Abstract][Full Text] [Related]
39. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Gould TD; Einat H; O'Donnell KC; Picchini AM; Schloesser RJ; Manji HK Neuropsychopharmacology; 2007 Oct; 32(10):2173-83. PubMed ID: 17299510 [TBL] [Abstract][Full Text] [Related]
40. Preliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorder. Siegel M; Beresford CA; Bunker M; Verdi M; Vishnevetsky D; Karlsson C; Teer O; Stedman A; Smith KA J Child Adolesc Psychopharmacol; 2014 Sep; 24(7):399-402. PubMed ID: 25093602 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]